Based on the above-mentioned evidence, it is plausible that dysregulated GBA levels could represent a common feature in PD, whereas loss-of-function GBA mutations could constitute the specific trigger responsible for PD development in the GBA-associated disease. This evidence concerns the gene GBA1 and Parkinson disease.